全文获取类型
收费全文 | 1904262篇 |
免费 | 135884篇 |
国内免费 | 5233篇 |
专业分类
耳鼻咽喉 | 24746篇 |
儿科学 | 61474篇 |
妇产科学 | 51805篇 |
基础医学 | 287368篇 |
口腔科学 | 53979篇 |
临床医学 | 175292篇 |
内科学 | 366882篇 |
皮肤病学 | 41435篇 |
神经病学 | 154165篇 |
特种医学 | 67177篇 |
外国民族医学 | 448篇 |
外科学 | 265465篇 |
综合类 | 36921篇 |
现状与发展 | 1篇 |
一般理论 | 604篇 |
预防医学 | 162742篇 |
眼科学 | 43018篇 |
药学 | 143163篇 |
6篇 | |
中国医学 | 4614篇 |
肿瘤学 | 104074篇 |
出版年
2021年 | 16742篇 |
2019年 | 17656篇 |
2018年 | 24648篇 |
2017年 | 18091篇 |
2016年 | 19555篇 |
2015年 | 22138篇 |
2014年 | 30075篇 |
2013年 | 46096篇 |
2012年 | 64443篇 |
2011年 | 68472篇 |
2010年 | 39387篇 |
2009年 | 35741篇 |
2008年 | 62082篇 |
2007年 | 65717篇 |
2006年 | 65743篇 |
2005年 | 63355篇 |
2004年 | 60360篇 |
2003年 | 57274篇 |
2002年 | 55655篇 |
2001年 | 83144篇 |
2000年 | 85824篇 |
1999年 | 71617篇 |
1998年 | 20030篇 |
1997年 | 17787篇 |
1996年 | 17810篇 |
1995年 | 16780篇 |
1994年 | 15606篇 |
1992年 | 55751篇 |
1991年 | 55238篇 |
1990年 | 54058篇 |
1989年 | 51434篇 |
1988年 | 47598篇 |
1987年 | 46569篇 |
1986年 | 44339篇 |
1985年 | 42282篇 |
1984年 | 31721篇 |
1983年 | 27049篇 |
1982年 | 15926篇 |
1979年 | 29482篇 |
1978年 | 21081篇 |
1977年 | 17460篇 |
1976年 | 17041篇 |
1975年 | 18106篇 |
1974年 | 21974篇 |
1973年 | 21292篇 |
1972年 | 20115篇 |
1971年 | 18928篇 |
1970年 | 17529篇 |
1969年 | 16298篇 |
1968年 | 15489篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
R González-Amaro L Baranda C Abud-Mendoza J F Salazar-González B Moncada R Garcia J Alcocer-Varela 《International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association》1987,55(4):651-656
Lepromatous leprosy is characterized by immune anergy and abnormal suppressor T-cell function. Contrasuppressor cells are a subset of CD8+, vicia villosa-adherent T lymphocytes. T-contrasuppressor (Tcs) cells act on T-helper cells to cause them to become unresponsive to the action of T-suppressor cells. In 8 lepromatous (LL) and 7 tuberculoid (TT) patients, and 6 healthy contacts we studied the percent of the following lymphocyte subsets: CD3+, CD4+, CD8+, Ia+, vicia villosa+ (VV+), CD8, VV+, VV, Ia+, and Ia, Tac+. This was done in baseline status as well as post-stimulation with recombinant gamma interferon (rIFN-gamma). We found that peripheral blood mononuclear cells from LL and TT patients and controls exhibit a similar number of putative contrasuppressor lymphocytes (CD8, VV+ cells). However, in the contrasuppressor subset from LL patients we found a low percent of Ia+ (p less than 0.05 compared to controls or TT). In the three groups studied, the rIFN-gamma enhanced the percent of Ia+ lymphocytes in the CD8, VV+ cell subpopulation. However, the CD8, VV+ lymphocytes from LL patients, despite the effect of rIFN-gamma, continue to have a low percent of Ia+ cells (p less than 0.05 compared to controls or TT). These findings suggest that LL patients might have abnormalities in the contrasuppressor immune circuit. Future functional studies on the role of Tcs cells in the anergy seen in LL will be required in order to define the apparent dysfunction occurring in this disease. 相似文献
992.
Mikael Hellström Bo Jacobsson Ulf Jodal Jan Winberg Anders Odén 《Pediatric nephrology (Berlin, Germany)》1987,1(3):269-275
This study presents the result of 12–21 years' follow-up in a group of children with neonatal urinary tract infection (onset within 1 month after birth) in whom early renal growth retardation was noted without concomitant classical renal scarring. In all cases the neonatal infection was diagnosed and treated within a few days of onset and the patients were closely supervised thereafter. Renal length, parenchymal thickness and area were measured at urography. At first follow-up (22 children, mean age 4.1 years) a significant reduction of renal parenchymal thickness was noted. Long-term follow-up (18 patients, mean age 17 years) demonstrated a normalization of renal size in the entire group, although less complete in the subgroup with reflux. There were two major findings in the present study. Firstly, renal growth retardation was seen after neonatal infection, both with and without reflux. Secondly, normalization of renal size in previously small kidneys was demonstrated, suggesting that growth retardation can be a reversible phenomenon. The tendency for such normalization was slightly more marked in children without reflux. Reduction of parenchymal thickness without calyceal deformity, therefore, does not necessarily mean irreversible damage, and differentiation between permanent scarring and temporary growth retardation can thus only be made at later follow-up, possibly not until after puberty. The demonstration of renal growth retardation in spite of early diagnosis and treatment emphasizes the great vulnerability of the kidney in the newborn. 相似文献
993.
994.
995.
Role of cellular retinoic acid binding protein (cRABP) in patients with large bowel cancer 总被引:1,自引:0,他引:1
G Di Fronzo V Cappelletti P Miodini L Bertario G Ravasi 《Cancer Detection and Prevention》1987,10(5-6):327-333
The presence of cellular retinoic acid binding protein (cRABP) was analyzed in 13 consecutive patients with large bowel cancer (one right colon and 12 rectum-sigmoid, classified as three Duke B, eight C, and two D). Specimens of neoplastic tissue and of adjacent mucosa were obtained at surgery, and cRABP was determined by an assay based on incubation of partially purified cytosol with labeled retinoic acid and ultracentrifugation in sucrose density gradients. Sixty-one percent of tumors contained detectable levels of cRABP, whereas 58.3% of normal mucosal specimens were positive for cRABP. Among the positive tumors 62.5% contained cRABP also in the corresponding mucosa; in the group of cRABP-negative tumors, 40% showed cRABP in the adjacent mucosa. No correlation could be established with the grading or the stage of the tumors; however, interestingly, 100% (three cases) of gelatinous carcinomas were cRABP positive. Since cRABP seems to be a character of neoplastic cells contrary to normal ones, it would be interesting to investigate the conditions that influence the presence of this protein in normal appearing mucosa adjacent to carcinoma. 相似文献
996.
S B Wieslander B T Mortensen L Binderup N I Nissen 《European journal of haematology》1987,39(1):35-38
10 patients with CLL and 2 with CML were treated with gradually increasing doses of 1 alpha(OH)D3, up to 4 micrograms daily during 6 wk. 3 patients with preleukemia and 1 with myelofibrosis were treated with 2 micrograms daily of 1 alpha(OH)D3 for a prolonged period up to 17 wk. The treatment with 1 alpha (OH)D3 did not result in changes of disease parameters in any of the patients under study. Receptor studies for 1,25(OH)2D3 were performed in 8 CLL patients and revealed only 1 patient with increased specific receptor binding capacity. The maximum tolerable dose of 1 alpha(OH)D3 varied individually, but was in the range of 2-4 micrograms daily. 相似文献
997.
998.
A significant increase of LDL-apolipoprotein B by 13% and LDL-cholesterol by 19% was observed in a group of 9 patients with hyperlipoproteinaemia Type III after bezafibrate treatment. Additional administration of colestipol caused a significant decrease of both LDL-apolipoprotein B by 18% and LDL-cholesterol by 25%. In 10 patients of hyperlipoproteinaemia Type IIb a significant decrease of both LDL-apolipoprotein B by 28% and LDL-apolipoprotein B by 18% was observed after bezafibrate therapy. When bezafibrate was given together with colestipol a further decrease of both LDL-cholesterol by 17% and LDL-apolipoprotein B by 16% occurred. HDL-cholesterol concentration increased significantly in both groups of hyperlipaemic patients during therapy. This may be the effect of both bezafibrate and colestipol. It is concluded that bile acid resins may effectively prevent the LDL-cholesterol concentration increase observed sometimes after clofibrate analogues. 相似文献
999.
1000.
The effects of two promoters of hepatocarcinogenesis--phenobarbital and butylated hydroxytoluene (BHT)--on five hepatic biochemical parameters were examined in adult female rats. Phenobarbital given orally in two doses each of 110 mg/kg 21 and 4 hr before the rats were killed caused large increases in hepatic ornithine decarboxylase (ODC) activity and cytochrome P-450 content. Extending the number of phenobarbital treatments to five increased the hepatic enzyme induction and also caused a minor decrease in hepatic glutathione and a small increase in serum alanine aminotransferase activity. Two oral doses of 700 mg BHT/kg (20% of the LD50) caused hepatic DNA damage and induction of both ODC activity and cytochrome P-450 content. When the dose of BHT was reduced from 700 to 140 mg/kg no significant effects on the biochemical parameters were found. Both promoters of hepatocarcinogenesis were identified by their induction of ODC, a marker for promotional potential, but only BHT showed a potential for carcinogenic initiation. The biochemical parameters examined, particularly the alkaline elution technique for DNA damage, ornithine decarboxylase activity and serum alanine aminotransferase, may constitute a useful assay system for examining a compound's potential for carcinogenic initiation, carcinogenic promotion and cellular toxicity. 相似文献